
Please try another search
Tissue Repair Ltd, a clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. It is developing TR-987, including Glucoprime technology for the treatment of chronic wounds, burns, and other complex wounds; and TR Pro+ for aftercare of minimally invasive cosmetic procedures. The company was incorporated in 2012 and is based in Chatswood, Australia.
Name | Age | Since | Title |
---|---|---|---|
Vaclav Vetvicka | - | - | Member of Scientific Advisory Board |
Michael Woodward | - | - | Member of Scientific Advisory Board |
Mitchel P. Goldman | - | - | Member of Scientific Advisory Board |
Thomas E. Serena | - | - | Member of Scientific Advisory Board |
Graham Edmund Kelly | 80 | - | Chief Scientific Advisor |
Patryk Kania | - | 2024 | Non-Executive Director |
Alistair McKeough | - | 2024 | Non-Executive Chairman |
Tony Charara | - | 2012 | Co-Founder, CEO & Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review